Molgramostim Nebulizer Solution Expanded Access Program Protocol | MicrobiomeTrials← Back to trialsNCT06546098
Molgramostim Nebulizer Solution Expanded Access Program Protocol
AVAILABLEEXPANDED_ACCESS
Trial Details
Locations- University of California, Los Angeles, California, United States
- University Florida Health, Gainesville, Florida, United States
- University of Maryland School of Medicine, Baltimore, Maryland, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Duke University Hospital, Durham, North Carolina, United States
- WakeMed Raleigh, Raleigh, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- AGH Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
- UT Southwestern Medical Center, Dallas, Texas, United States
Other microbiome trials you might be interested in
Pulmonary Alveolar Proteinosis
The major goal of Part A of this study is to establish a National PAP Registry to help make reliable new research tests …
Cincinnati, United StatesEst. completion Dec 2030
Autoimmune Pulmonary Alveolar Proteinosis
The goal of this open-label study is to study molgramostim as a treatment for autoimmune pulmonary alveolar proteinosis …
München, GermanyEst. completion Jun 2027